Extract notice to the Minister

Taro-Tofacitinib

Common name / Subject : tofacitinib (citrate de)
Name of the manufacturer : Taro
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription -Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on March 01, 2023

Subscribe to our newsletter now

Subscription